Saxenda® (liraglutide) may cause serious side effects, including: Possible thyroid tumors, including cancer. Tell your health care professional if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Saxenda® (liraglutide) and medicines that work like Saxenda® (liraglutide) caused thyroid tumors, including thyroid cancer. It is not known if Saxenda® (liraglutide) will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
Do not use Saxenda® (liraglutide) if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® (liraglutide) should be used with a reduced calorie diet and increased physical activity.
Do not use Saxenda® (liraglutide) if:
Read the Instructions for Use that comes with Saxenda® (liraglutide). Inject your dose of Saxenda® (liraglutide) under the skin (subcutaneously) in your stomach area (abdomen), upper leg (thigh), or upper arm, as instructed by your health care provider. Do not inject into a vein or muscle. Change (rotate) your injection site within the area you choose with each injection to reduce your risk of getting lumps under the skin (cutaneous amyloidosis). Do not use the same site for each injection
You should not change your dosing regimen or stop taking Saxenda® (liraglutide) as prescribed without discussing with your provider first. If you take too much Saxenda® (liraglutide), call your healthcare provider or seek medical advice promptly.
In particular, tell your provider if you have a past history of:
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
These serious side effects are rare, but can occur with Saxenda® (liraglutide). You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
You are encouraged to report negative side effects of prescription products to the FDA.
Visit fda.gov/medwatch or call 1-800-FDA-1088.
Disclaimer: Ozempic®, WeGovy®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Byetta® and Bydureon® are registered trademarks of Amylin Pharmaceuticals. Brightmeds has no affiliation with Novo Nordisk, Eli Lilly or Amylin Pharmaceuticals. The compounded products available as part of our Weight Loss Program are not made by Novo Nordisk, Eli Lilly or Amylin Pharmaceuticals or any company affiliated with Novo Nordisk, Eli Lilly or Amylin Pharmaceuticals.